FDA Investigator Rochelle L Cross

Rochelle L Cross has inspections in 11 countries as of 03 Nov 2023. Rochelle L Cross has collaborated with a combinined 2833 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
33
Last Inspection Date:
03 Nov 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, France, India, Ireland, Canada, China, Finland, Germany, Switzerland, Belgium
Co-Investigator(s):
Alan P Kurtzberg, Alanna Lmussawwir Bias, Alicia M Mozzachio, Amy M Cramer, Anastasia M Shields, Angela E Glenn, Anna Lazar, Anthony A Charity, Arsen Karapetyan, Ashar P Parikh, Azza Talaat, Barbara J Wilimczyk, Barbara Jwilimczyk Macri, Barry Rothman, Bonita S Chester, Carrie A Hughes, CDR Ileana Barreto Pettit, Charisse K Green, Charles M Edwards, Charles R Cote, RIC, Christine W Twohy, Concepcion Cruz, Jr, Daniel J Grabicki, Daniel J Roberts, David A Oluwo, Dell S Moller, Devon Jenkins, Djamila Harouaka, Douglas C Kovacs, Dr. Robert C Horan, MD, Dr. S Nar Ali, PhD, Edwin Martinez, Elizabeth D Connell, Emest F Bizjak, Eric L Dong, BS, Erika V Butler, Farhana Khan, Francis A Guidry, Frederick Razzaghi, Gayle S Lawson, Grace E Mcnally, Gwyn G Dickinson, Ivis Lnegron Torres, Jacob M Dyer, James P Mcreavey, John A Gonzalez, Jonah S Ufferfilge, Jonathan G Matrisciano, Jorge L Guadalupe, Jose Acruz Gonzalez, Jose Alopez Rubet, Jose E Melendez, DDC, Joseph F Mcginnis, RPh, Joseph L Despins, PhD, Joy Rkozlowski Klena, Justine Tomasso, Karen E D'orazio, Karen Takahashi, Katherine Szestypalow, Kathryn E Ogger, Kelli F Dobilas, Kellia N Hicks, Kenneth H Williams, Kent C Faul, Kevin P Foley, Kham Phommachanh, Kimberley A Hoefen, Kristy A Zielny, Krystyna M Kitson, Larry K Austin, Lata C Mathew, PhD, Latorie S Jones, Lawrence Harmon, Jr, LCDR Debra Emerson, Liatte Kreuger, PharmD, Lisa L Flores, Loretta Nemchik, Luella J Rossi, Luis A Dasta, Marcelo O Mangalindan, Jr, Marea K Harmon, Margaret M Sands, Maria Estrella, Marie A Fadden, Mary E Storch, Michael R Goga, Michele L Obert, Michele Perry Williams, Miguel A Martinez, Monica M Mcclure, Mra Davism, Mra Mcculloughj, Nadeem I Chaudhry, Nancy M Espinal, Nicholas L Hunt, Nicholas L Paulin, Nicole E Knowlton, Niketa Patel, Noreen Muniz, Pankaj H Amin, Parul M Patel, Patrick C Klotzbuecher, Patsy J Domingo, Patty P Kaewussdangkul, Paul A Bonneau, Paul L Bellamy, Peter C Chow, Peter E Baker, Pratik S Upadhyay, DDC, Qin Xu, Rajiv R Srivastava, Ralph A Erickson, Ralph H Vocque, Raquel Gonzalez Rivera, Reba A Gates, Rebecca Rodriguez, Regina T Brown, Richard E Needham, Richard L Rutherford, Robert C Henry, Robert J Martin, Rochelle L Campbell, Roger F Zabinski, Rosario D'costa, Russell J Glapion, Samuel T Walker, Santos E Camara, Sarah E Mcmullen, Satheesh Thomas, Scott T Ballard, Sharon K Thoma, PharmD, Simone E Pitts, Sneha S Patel, Stephen D Brown, Steven A Gonzales, Steven D Kehoe, Steven M Weinman, Susan W Ting, Susanna E Ford, Analyst, Syed N Ali, Taichun Qin, PhD, Tamil Arasu, PhD, Tara G Bizjak, Tara R Gooen, Temar Q Williams, Tina M Pawlowski, Unnee Ranjan, William A Warnick, William D Tingley, Yasamin Ameri, Yumi J Hiramine, Yvesna C Blaise, Yvette I Henry, Yvette I Johnson, Yvins Dezan, Yvonne C Mcknight, Yvonne E Lozano, Zachary A Bogorad

Rochelle L Cross's Documents

Publish Date Document Type Title
November, 2003 EIR Complete Analysis Laboratories Inc - EIR, 2003-11-21
November, 2003 FDA 483 Complete Analysis Laboratories Inc - Form 483, 2003-11-21
March, 2018 FDA 483 Giacomina Massaro-Giordano M.D. - Form 483, 2018-03-09
October, 2020 FDA 483 Patricia Kropf MD - Form 483, 2020-11-13

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.


Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more